Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
25993 | 219 | 29.9 | 71% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
116 | 23742 | STAPHYLOCOCCUS AUREUS//MRSA//METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SECTOR MICROBIOL | Address | 1 | 38% | 1% | 3 |
2 | STAPHYLOCOCCUS AUREUS BACTEREMIA | Author keyword | 1 | 27% | 2% | 4 |
3 | STAPHYLOCOCCUS AUREUS BACTERAEMIA | Author keyword | 1 | 33% | 1% | 3 |
4 | 1971 2000 | Author keyword | 1 | 50% | 0% | 1 |
5 | ALBERTA HLTH SERV CALGARY AREA | Address | 1 | 50% | 0% | 1 |
6 | ANTIBIOTIC THERAPY DURATION | Author keyword | 1 | 50% | 0% | 1 |
7 | BACTEREMIA IN ELDERLY | Author keyword | 1 | 50% | 0% | 1 |
8 | COMPLICATED BACTERAEMIA | Author keyword | 1 | 50% | 0% | 1 |
9 | MERS | Address | 1 | 50% | 0% | 1 |
10 | S AUREUS BACTEREMIA | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TEICHOIC ACID ANTIBODY | 4 | 75% | 1% | 3 |
2 | SHORT COURSE THERAPY | 3 | 26% | 4% | 9 |
3 | DISEASES CONSULTATION | 1 | 50% | 0% | 1 |
4 | BACTERIAL GENOTYPE | 0 | 33% | 0% | 1 |
5 | STREPTOCOCCUS SPECIES BACTEREMIA | 0 | 33% | 0% | 1 |
6 | CALGARY | 0 | 14% | 1% | 2 |
7 | PURIFIED CAPSULAR POLYSACCHARIDE | 0 | 25% | 0% | 1 |
8 | VERTEBRAL VEINS | 0 | 25% | 0% | 1 |
9 | COLONY COUNTS | 0 | 20% | 0% | 1 |
10 | HEMODIALYSIS DEPENDENT PATIENTS | 0 | 20% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Clinical management of Staphylococcus aureus bacteraemia | 2011 | 39 | 142 | 23% |
Importance of focus identification in the treatment of Staphylococcus aureus bacteraemia | 2002 | 22 | 59 | 29% |
SHORT-COURSE THERAPY OF CATHETER-RELATED STAPHYLOCOCCUS-AUREUS BACTEREMIA - A METAANALYSIS | 1993 | 86 | 29 | 38% |
PROSPECTIVE-STUDY OF 114 CONSECUTIVE EPISODES OF STAPHYLOCOCCUS-AUREUS BACTEREMIA | 1987 | 163 | 27 | 37% |
Staphylococcus aureus bacteremia | 2003 | 4 | 216 | 17% |
THE CURRENT SPECTRUM OF STAPHYLOCOCCUS-AUREUS INFECTION IN A TERTIARY CARE HOSPITAL | 1994 | 53 | 91 | 5% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SECTOR MICROBIOL | 1 | 38% | 1.4% | 3 |
2 | ALBERTA HLTH SERV CALGARY AREA | 1 | 50% | 0.5% | 1 |
3 | MERS | 1 | 50% | 0.5% | 1 |
4 | SERV REANIMAT MALAD INFECTIEUSES | 1 | 50% | 0.5% | 1 |
5 | DEPARMENT NEPHROL | 0 | 33% | 0.5% | 1 |
6 | FEDERAT SERV MED INTERNE | 0 | 33% | 0.5% | 1 |
7 | INSERM U1047 | 0 | 33% | 0.5% | 1 |
8 | CLIN PEDIAT UNIT | 0 | 25% | 0.5% | 1 |
9 | GRP INFECTOL | 0 | 25% | 0.5% | 1 |
10 | ST HYLOCOCCAL | 0 | 13% | 0.9% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000232172 | BLOOD CULTURE//BLOOD CULTURES//TIME TO POSITIVITY |
2 | 0.0000212421 | INFECTIVE ENDOCARDITIS//ENDOCARDITIS//PROSTHETIC VALVE ENDOCARDITIS |
3 | 0.0000201614 | DAPTOMYCIN//TELAVANCIN//HVISA |
4 | 0.0000198450 | PANTON VALENTINE LEUKOCIDIN//MRSA//CA MRSA |
5 | 0.0000168172 | AGAR GEL DIFFUSION//ERYTHROBLASTIC ISLET//IMMUNOBLOTS WESTERN BLOTS |
6 | 0.0000119926 | STENT INFECTION//BLOOD VESSELS FOREIGN BODIES//ABT INFECT KRANKHEITEN |
7 | 0.0000101777 | TETRACYCLINE RESISTANCE PLASMID//BACTERIOPHAGE TYPING//PI9789 |
8 | 0.0000098555 | CATHETER RELATED BLOODSTREAM INFECTION//CATHETER RELATED INFECTION//CENTRAL VENOUS CATHETER |
9 | 0.0000076682 | BUNDESSTAATL BAKTERIOL SEROL UNTERSUCHUNGSANSTALT//KINDERHEILKUNDE KLIN PEDIATINFEKT ABT//ANTIMICROBIAL INTERACTION |
10 | 0.0000073360 | ANTI INFECTIOUS ACTIVITY//DICHLOROMETHYLENE DIPHOSPHATE//FLAP INJURY |